The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Webcast
Donna Gammarato discusses the importance of creating specialized value analysis teams to analyze resource utilization and reduce costs
Guides/Reports
Download Report
Webcast
Professional Coach Mark Noon discusses the types of skills and actions that a leader needs to create a team-oriented culture.
Guides/Reports
Most of us have heard the term “population health” but is it simply a healthcare buzzword or a program that can truly drive better costs, qua